Connected Transaction Disclosure: Annual Cap Setting for Continuing Connected Transactions

The SFC and HKEX’s joint consultation paper published in December 2024 on proposed enhancements to the Listing Rules for connected transactions has shifted the compliance burden from a periodic disclosure exercise to a continuous, forward-looking obligation. The most material change under the new regime, expected to be codified in Listing Rules Chapter 14A by mid-2025, is the mandatory annual cap setting for all continuing connected transactions (CCTs). For listed issuers, this is not merely a technical amendment; it represents a fundamental recalibration of how related-party dealings are governed, with direct consequences for working capital management, board discretion, and shareholder approval thresholds. The 2024 consultation data from the HKEX revealed that over 40% of CCT-related enforcement actions in the preceding three years stemmed from inadequate or missing annual caps, underscoring a systemic weakness in current practice. This article dissects the mechanics of annual cap setting under the proposed rules, provides a structured framework for calculating caps that withstands regulatory scrutiny, and examines the practical implications for sponsors, audit committees, and CFOs navigating the 2025 compliance cycle.

The Regulatory Framework: From Reactive Disclosure to Proactive Cap Setting

The Current Regime Under Chapter 14A and Its Shortcomings

The existing Listing Rules Chapter 14A, as amended in 2021, requires that CCTs be conducted on normal commercial terms and within a fixed monetary cap approved by independent shareholders or the board, depending on the transaction’s size relative to the issuer’s market capitalisation or revenue. However, the current framework permits issuers to set caps based on historical expenditure plus a blanket growth percentage, often without rigorous justification. This practice has led to two systemic problems: first, caps are frequently set too low, triggering frequent waiver applications to the HKEX; second, caps are set too high, rendering the shareholder approval process meaningless as a governance safeguard.

The HKEX’s 2024 consultation paper (paragraphs 38-45) explicitly identifies these deficiencies, noting that approximately 28% of CCT cap amendments between 2020 and 2023 were initiated within six months of the original approval, indicating systemic underestimation. The proposed rules address this by requiring that annual caps be set with reference to a “reasonable and defensible methodology” that includes a forward-looking projection supported by verifiable data, rather than historical averages alone.

The Proposed 2025 Rule Changes: Mandatory Annual Caps and Enhanced Justification

Under the proposed amendments, every CCT must have a distinct annual cap for each financial year of the agreement’s term. The cap must be calculated using one of three prescribed methodologies: (i) a bottom-up build based on unit volume and unit price projections; (ii) a top-down allocation from a group-level budget approved by the board; or (iii) a statistical extrapolation from a minimum of three years of historical data, adjusted for known changes in business operations. The issuer must also disclose the methodology, key assumptions, and sensitivity analysis in the circular or announcement seeking shareholder approval.

The HKEX has indicated that it will treat a cap as “manifestly unreasonable” if it exceeds the projected maximum by more than 25% without a documented justification, such as a material acquisition or divestiture during the period. This 25% threshold, while not yet codified in the final rules, has been consistently referenced in HKEX staff guidance notes from Q1 2025, and issuers should treat it as a de facto ceiling.

The Mechanics of Annual Cap Calculation: A Data-Driven Approach

Bottom-Up Build: The Preferred Methodology for Operational CCTs

For CCTs involving the sale or purchase of goods, the provision of services, or the leasing of assets, the bottom-up build is the most defensible methodology. It requires the issuer to disaggregate the projected transaction volume into its constituent components: the expected number of transactions, the average unit price per transaction, and any escalation clauses embedded in the underlying agreement.

Consider a typical CCT between a Hong Kong-listed Main Board issuer and its BVI-incorporated subsidiary that supplies raw materials. The issuer must first establish the projected production volume for the relevant year, based on the issuer’s board-approved budget. The budget itself must be supported by third-party demand forecasts, such as purchase orders from the issuer’s customers or independent market research. The unit price must be set by reference to arm’s-length benchmarks, which under Listing Rule 14A.55 must be documented in a transfer pricing report prepared by a qualified independent valuer.

If the unit price is variable, the cap must incorporate a range of outcomes. The HKEX’s preferred approach is to set the cap at the 95th percentile of projected outcomes, based on Monte Carlo simulation or a similar statistical method. For issuers without the in-house capability to run such simulations, the fallback is to apply a 20% buffer above the base-case projection, provided that the base-case is itself derived from a verifiable source.

Top-Down Allocation: For Group-Level Service Agreements

Where the CCT involves shared services, such as centralised treasury management, IT infrastructure, or administrative support, the top-down allocation methodology is more appropriate. The issuer must first establish the total cost of the shared service function at the group level, as recorded in the management accounts for the preceding financial year. This total cost must then be allocated among the participating entities using a cost allocation key that is objective, consistent, and disclosed in the circular.

The HKEX has stated in its 2024 consultation response that it will scrutinise allocation keys that are based on revenue or headcount without a clear causal link to the service being provided. For example, allocating IT costs based on headcount is acceptable only if the IT service is primarily user-access based; if the service is transaction-volume based, the allocation key should be the number of transactions processed by each entity. The cap must be set at the highest projected allocation for the issuer, not the average, to avoid the risk of underestimation.

Shareholder Approval and Disclosure: Navigating the 2025 Compliance Cycle

The Three-Tier Approval Threshold Under the Proposed Rules

The proposed rules retain the three-tier approval structure currently in place under Listing Rule 14A.35, but with adjusted percentage thresholds. For CCTs where the annual cap exceeds 5% of the issuer’s revenue or market capitalisation, independent shareholders must approve the cap. For caps between 1% and 5%, board approval suffices, but the circular must include a fairness opinion from a financial adviser. For caps below 1%, only a disclosure in the annual report is required.

The critical change is that the cap must be approved for each financial year separately. Even if the underlying CCT agreement spans five years, the issuer must seek fresh shareholder approval for each year’s cap. This eliminates the current practice of obtaining a single “umbrella” cap for the entire contract term, which the HKEX has identified as a source of governance risk.

Disclosure Requirements: The Circular Must Be a Standalone Document

Under the proposed Listing Rule 14A.68, the circular for a CCT cap approval must contain a standalone section titled “Basis of the Annual Cap”, which sets out the methodology, key assumptions, and sensitivity analysis. The HKEX expects this section to be written in plain language, not legal boilerplate, and to include a table showing the projected transaction volume, unit price, and cap amount for each year of the agreement.

Where the cap is based on a statistical model, the issuer must disclose the model’s inputs, the confidence interval used, and the result of any back-testing against historical data. Failure to provide this information is a ground for the HKEX to request a supplementary circular, which can delay the general meeting by up to four weeks.

Practical Implications for Sponsors and Audit Committees

The Sponsor’s Role: From Transaction Advisory to Continuous Monitoring

The proposed rules impose a new obligation on sponsors to confirm, in the sponsor’s legal opinion, that the annual cap has been set in accordance with the prescribed methodology and that the underlying assumptions are reasonable. This goes beyond the current requirement under the Code of Conduct for Sponsors (paragraph 17.6), which only requires the sponsor to confirm that the transaction is on normal commercial terms.

Sponsors must now perform a “reasonableness check” on the cap calculation, which includes verifying the source data, testing the statistical model, and interviewing management on the key assumptions. The HKEX has indicated that it will hold sponsors liable for manifestly unreasonable caps, with potential sanctions including a suspension of the sponsor’s registration under the Securities and Futures Ordinance (Cap. 571).

The Audit Committee’s Oversight: A Forward-Looking Mandate

The audit committee’s role under the proposed rules shifts from a historical review to a forward-looking assessment. The committee must review and approve the cap methodology before it is presented to the board, and must receive quarterly reports comparing actual transaction volumes against the cap. If actual volumes exceed 80% of the cap at any point during the year, the committee must consider whether a cap increase is necessary.

This 80% trigger point is a new requirement under the proposed Listing Rule 14A.55A, designed to prevent last-minute waiver applications. The audit committee must document its rationale for any decision not to seek a cap increase, and that documentation must be available for HKEX inspection.

Actionable Takeaways

1. Issuers must implement a forward-looking cap-setting process that uses a documented methodology — bottom-up build, top-down allocation, or statistical extrapolation — and avoid relying solely on historical expenditure plus a blanket buffer.

2. The 25% threshold above the projected maximum is a de facto ceiling for cap reasonableness under HKEX staff guidance from Q1 2025; any cap exceeding this range must be justified by a material change in business operations, such as a significant acquisition or new contract.

3. Sponsors must verify the cap methodology as part of their legal opinion under the proposed rules, and the verification must include a reasonableness check on the underlying assumptions, source data, and statistical model.

4. Audit committees must adopt a quarterly monitoring cadence with an 80% trigger point for considering cap increases, and must document all decisions not to seek an increase for potential HKEX inspection.

5. Circulars for CCT cap approvals must include a standalone “Basis of the Annual Cap” section with a table of projected volumes, unit prices, and cap amounts for each year, written in plain language and supported by sensitivity analysis.